Alpha GPC: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 5: | Line 5: | ||
UPDATE: As of March 2025 an application for authorisation as a Novel food has been lodged with EFSA, when a decision is reached this page will be updated. | UPDATE: As of March 2025 an application for authorisation as a Novel food has been lodged with EFSA, when a decision is reached this page will be updated. | ||
UPDATE: As of May 2026, it has passed the safety assessment by EFSA # [https://efsa.onlinelibrary.wiley.com/doi/10.2903/j.efsa.2026.10008] | UPDATE: As of May 2026, it has passed the safety assessment by EFSA #[https://efsa.onlinelibrary.wiley.com/doi/10.2903/j.efsa.2026.10008] | ||
Revision as of 15:00, 19 May 2026
L-alpha-glycerylphosphorylcholine.
Commonly requested in sport and nootropic products. This is likely medicinal according to the HFMA.
UPDATE: As of March 2025 an application for authorisation as a Novel food has been lodged with EFSA, when a decision is reached this page will be updated.
UPDATE: As of May 2026, it has passed the safety assessment by EFSA #[1]